Levitt Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Levitt Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$704K	Sell	22,144 -38,981	-64%	-$1.16M	1.69%	22
2014 Q1	$1.58M	Buy	61,125 +34,806	+132%	+$950K	1.5%	18
2013 Q4	$685K	Sell	26,319 -597	-2%	-$16.7K	0.84%	37
2013 Q3	$735K	Sell	26,916 -1,124	-4%	-$35.3K	1.03%	29
2013 Q2	$1.02M	Buy	+28,040	New	+$1.01M	1.77%	8

Other funds holding CLMT

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EAM

Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

IMS

Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Corrado Advisors Ramsey, New Jersey $217M AUM 26.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

Levitt Capital Management's CLMT Position: Q2 2014 in Review

Levitt Capital Management reduced its Calumet Specialty Products (CLMT) stake by 64% in Q2 2014, selling an estimated $1.16M and leaving 22,144 shares worth $704K. The position accounts for 1.69% of the portfolio, ranked #22.

Levitt Capital Management first reported a position in CLMT in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.58M in Q1 2014. 124 funds tracked by Wall St. Rank hold CLMT as of Q2 2014.

Levitt Capital Management held 22,144 shares of Calumet Specialty Products worth $704K as of Q2 2014.
Levitt Capital Management sold 38,981 Calumet Specialty Products shares in Q2 2014, an estimated $1.16M.
Calumet Specialty Products made up 1.69% of Levitt Capital Management's portfolio in Q2 2014, its #22 holding.
Levitt Capital Management first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 5 quarters since.
Levitt Capital Management's Calumet Specialty Products position peaked at $1.58M in Q1 2014.
124 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2014.

Based on Levitt Capital Management's 13F filing for Q2 2014, filed 21 Jul 2014.